/GERM
GERM Stock - ETFMG Treatments, Testing and Advancements ETF
Financial Services|Asset ManagementAMEX
$19.16-0.29%
$0.06 (-0.29%) • Sep 5
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.57
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $21.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GERM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$18.97 – $19.35
TARGET (TP)$22.03
STOP LOSS$17.63
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.02
52W High$20.20
52W Low$16.32
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
GERMLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about GERM
What is GERM's current stock price?
ETFMG Treatments, Testing and Advancements ETF (GERM) is currently trading at $19.16 per share. The stock has moved -0.29% today.
What is the analyst price target for GERM?
No analyst price targets are currently available for this stock.
What sector is ETFMG Treatments, Testing and Advancements ETF in?
ETFMG Treatments, Testing and Advancements ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is GERM's market cap?
ETFMG Treatments, Testing and Advancements ETF has a market capitalization of $0.01 billion, making it a small-cap company.
Does GERM pay dividends?
No, ETFMG Treatments, Testing and Advancements ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBAD
B.A.D. ETF
$11.91
Mkt Cap: $0.0B
CHIK
Global X MSCI China Information Technology ETF
$13.20
Mkt Cap: $0.0B
CUBS
Asian Growth Cubs ETF
$18.85
Mkt Cap: $0.0B
EEMD
AAM S&P Emerging Markets High Dividend Value ETF
$20.09
Mkt Cap: $0.0B
ERSX
ERShares NextGen Entrepreneurs ETF
$11.27
Mkt Cap: $0.0B
HCOM
Hartford Schroders Commodity Strategy ETF
$14.55
Mkt Cap: $0.0B
HEET
Hartford Schroders ESG US Equity ETF
$24.59
Mkt Cap: $0.0B
INDF
Nifty India Financials ETF
$31.51
Mkt Cap: $0.0B
KALL
KraneShares MSCI All China Index ETF
$22.28
Mkt Cap: $0.0B
PLAT
WisdomTree Growth Leaders Fund
$30.49
Mkt Cap: $0.0B
Explore stocks similar to GERM for comparison